Last reviewed · How we verify

NCT04771026: SGA

The Effectiveness of Preemptive Nebulized Dexamethasone in Reducing Post-Operative Sore Throat in Supraglottic Airway

Completed NA Last updated 28 September 2023
What this trial tests

NA trial testing Dexamethasone in Sore Throat in 140 participants. Completed in 31 December 2021.

Timeline
1 December 2020
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorUniversiti Sains Malaysia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment140
Start date1 December 2020
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Sains Malaysia — full company profile →

Who can join

Adults 18 to 70, any sex, with Sore Throat or Hoarseness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to study the effectiveness of preoperatively nebulized dexamethasone in reducing the incidence and severity of Post Operative Sore Throat, POST in patients undergoing surgery under general anesthesia using the Ambu® AuraGainTM SGA device, with secondary aims of determining the effectiveness of dexamethasone in reducing post-operative cough severity and hoarseness of voice

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexamethasone

Trials testing the same drug.

Other recruiting trials for Sore Throat

Currently open trials in the same condition.

Other Universiti Sains Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04771026.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing